Scotia Capital’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-11,597
Closed -$61K 828
2020
Q4
$61K Buy
11,597
+18
+0.2% +$71 ﹤0.01% 735
2020
Q3
$33K Sell
11,579
-90
-0.8% -$331 ﹤0.01% 691
2020
Q2
$41K Hold
11,669
﹤0.01% 608
2020
Q1
$27K Hold
11,669
﹤0.01% 619
2019
Q4
$123K Hold
11,669
﹤0.01% 707
2019
Q3
$100K Hold
11,669
﹤0.01% 692
2019
Q2
$134K Hold
11,669
﹤0.01% 689
2019
Q1
$164K Hold
11,669
﹤0.01% 659
2018
Q4
$121K Buy
+11,669
New +$172K ﹤0.01% 621

Other funds holding PTEN

Scotia Capital's PTEN Position: Q1 2021 in Review

Scotia Capital sold out of Patterson-UTI (PTEN) in Q1 2021, closing a stake of 11,597 shares — an estimated $61K sold.

Scotia Capital first reported a position in PTEN in Q4 2018 and held it in 9 quarters. The position peaked at $164K in Q1 2019. 212 funds tracked by Wall St. Rank hold PTEN as of Q1 2021.

  • Scotia Capital reported no remaining Patterson-UTI position as of Q1 2021 after selling out during the quarter.
  • Scotia Capital sold 11,597 Patterson-UTI shares in Q1 2021, an estimated $61K.
  • Scotia Capital first reported a position in Patterson-UTI in Q4 2018 and held it in 9 quarters.
  • Scotia Capital's Patterson-UTI position peaked at $164K in Q1 2019.
  • 212 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2021.

Based on Scotia Capital's 13F filing for Q1 2021, filed 6 May 2021.